REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

Serial Number 97750693
733

Registration Progress

Application Filed
Jan 11, 2023
Under Examination
Jul 25, 2023
Approved for Publication
May 30, 2023
Published for Opposition
May 30, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Jan 25, 2026 163 days

Trademark Image

REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

Basic Information

Serial Number
97750693
Filing Date
January 11, 2023
Published for Opposition
May 30, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 17, 2025
Application
Pending
Classes
010

Rights Holder

United Therapeutics Corporation

03
Address
1000 Spring Street
Silver Spring, MD 20910

Ownership History

United Therapeutics Corporation

Original Applicant
03
Silver Spring, MD

United Therapeutics Corporation

Owner at Publication
03
Silver Spring, MD

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
163 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
January 25, 2026
Extension Available
Until July 25, 2024

Application History

29 events
Date Code Type Description Documents
Jul 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 17, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 17, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 24, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 23, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 23, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 3, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 3, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 3, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 25, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 30, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 30, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 10, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 21, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 21, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 3, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 2, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Drug delivery systems sold empty, namely, drug delivery pumps

Additional Information

Design Mark
The mark consists of the words REMOSENSE PUMP in the color blue and the words FOR REMODULIN (TREPROSTINIL) INJECTION in the color red with two arcs to the left of the wording in the colors green and red.
Color Claim
The color(s) green, blue and red is/are claimed as a feature of the mark.

Classification

International Classes
010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PUMP" AND "(TREPROSTINIL) INJECTION"